Clinical Trial Update: Calcitriol in Preventing Prostate Cancer in Patients With Prostatic Intraepithelial Neoplasia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating calcitriol to prevent prostate cancer in men with prostatic intraepithelial neoplasia has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer
• Prostatic Intraepithelial Neoplasia

Drugs mentioned

• Calcitriol (calcitriol)

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Precancerous/Nonmalignant Condition, Prostate Cancer | Phase 2 | Status: TERMINATED